Growth Metrics

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023)

Pacific Biosciences Of California (PACB) has 2 years of Restructuring Costs data on record, last reported at $63000.0 in Q4 2023.

  • For Q4 2023, Restructuring Costs changed N/A year-over-year to $63000.0; the TTM value through Dec 2024 reached $31.2 million, changed N/A, while the annual FY2023 figure was $9.0 million, N/A changed from the prior year.
  • Restructuring Costs reached $63000.0 in Q4 2023 per PACB's latest filing, down from $403000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $30.7 million in Q3 2021 and bottomed at $63000.0 in Q4 2023.